InvestorsHub Logo
Followers 48
Posts 3176
Boards Moderated 0
Alias Born 01/16/2012

Re: None

Tuesday, 04/24/2018 8:10:34 AM

Tuesday, April 24, 2018 8:10:34 AM

Post# of 111072
This month Creative Medical Technology Holdings, Inc. (USOTCQB: CELZ) announced new data demonstrating superior immune modulatory ability of its AmnioStem™ stem cell product when compared head-to-head with bone marrow, adipose tissue, and placental tissue mesenchymal stem cells. The Company is currently preparing an Investigational New Drug (IND) application with the FDA for use of its AmnioStem™ stem cell product for treatment of radiation toxicity.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CELZ News